Zymenex Is A Scandinavian Biopharmaceutical Company Focused On The Development And Commercialization Of Novel Enzyme Replacement Therapies For The Treatment Of Life Threateningrare Genetic Diseaseszymenex Is Developing Several Human Recombinant Enzymes That Can Be Used For Therapy Within Specific Disease Areasthe Products Are Expected To Be Able To Help Patientswho Today Have Serious Handicapsreduced Quality Of Life And A Markedly Reduced Life Expectancyenzyme Replacement Therapy Is A Well Known Treatment Method And There Are A Number Of Products On The Market Today That Validates The Company Conceptthe Company S Research And Development Focuses On Lysosomal Storage Diseaseswhich Is A Common Name For Human Diseaseswhere The Ability Of The Human Body To Break Down Specific Molecules In The Lysosomes In The Cells Is Reduced Or Impairedthe Diseases Most Often Affect Childrenthey Are Lethal And There Is No Therapy Available Today
No conferences found for this company.
| Company Name | Zymenex As |
| Country |
Denmark
|
| Address | N/A |
| Telephone | N/A |
| N/A |
